Education
About Us
Working with TipRanks
Follow Us
AnGes (JP:4563)
:4563
4563 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥43.00 - ¥98.00
Previous CloseN/A
Volume2.84M
Average Volume (3M)6.88M
Market Cap
¥23.22B
Enterprise Value¥23.88B
Total Cash (Recent Filing)¥1.71B
Total Debt (Recent Filing)¥271.00M
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.99
Shares Outstanding351,865,540
10 Day Avg. Volume6,185,390
30 Day Avg. Volume6,880,423
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)8.60
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
4563 FAQ
What was AnGes ’s price range in the past 12 months?
AnGes lowest stock price was ¥43.00 and its highest was ¥98.00 in the past 12 months.
What is AnGes ’s market cap?
AnGes ’s market cap is ¥23.22B.
When is AnGes ’s upcoming earnings report date?
AnGes ’s upcoming earnings report date is Aug 07, 2025 which is in 51 days.
How were AnGes ’s earnings last quarter?
AnGes released its earnings results on May 09, 2025. The company reported -¥3.99 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.99.
Is AnGes overvalued?
According to Wall Street analysts AnGes ’s price is currently Overvalued.
Does AnGes pay dividends?
AnGes does not currently pay dividends.
What is AnGes ’s EPS estimate?
AnGes ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnGes have?
AnGes has 351,865,540 shares outstanding.
What happened to AnGes ’s price movement after its last earnings report?
AnGes reported an EPS of -¥3.99 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of AnGes ?
Currently, no hedge funds are holding shares in JP:4563
Company Description
AnGes
AnGes, Inc. is a biopharmaceutical company based in Japan, primarily engaged in the research, development, and commercialization of gene-based medicines. The company's core focus is on the development of innovative treatments for diseases with significant unmet medical needs, including cardiovascular diseases, infectious diseases, and genetic disorders. AnGes is noted for its pioneering work in gene therapy and DNA vaccines, leveraging cutting-edge biotechnological advancements to create novel therapeutic solutions.
Technical Analysis
CanBas Co., Ltd.
―
Healios KK
―
StemRIM Inc.
―
Japan Tissue Engineering Co., Ltd.
―
CellSeed Inc.
―